[1]李大略,赵资文,刘兆礼,等.加速康复外科对合并有糖尿病的结直肠癌患者术后炎症反应与营养代谢的影响[J].医学信息,2019,32(07):67-72.[doi:10.3969/j.issn.1006-1959.2019.07.021]
　LI Da-lue,ZHAO Zi-wen,LIU Zhao-li,et al.Effect of Accelerated Rehabilitation Surgery on Postoperative Inflammatory Response and Nutrient Metabolism in Patients with Colorectal Cancer Complicated with Diabetes[J].Journal of Medical Information,2019,32(07):67-72.[doi:10.3969/j.issn.1006-1959.2019.07.021]
点击复制

加速康复外科对合并有糖尿病的结直肠癌患者术后炎症反应与营养代谢的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年07期
页码:
67-72
栏目:
论著
出版日期:
2019-04-01

文章信息/Info

Title:
Effect of Accelerated Rehabilitation Surgery on Postoperative Inflammatory Response and Nutrient Metabolism in Patients with Colorectal Cancer Complicated with Diabetes
文章编号:
1006-1959（2019）07-0067-06
作者:
李大略; 赵资文; 刘兆礼; 王东升
（青岛大学附属医院胃肠外科，山东 青岛 266003）
Author(s):
LI Da-lue; ZHAO Zi-wen; LIU Zhao-li; WANG Dong-sheng
(Department of Gastroenterology,Affiliated Hospital of Qingdao University,Qingdao 266003,Shandong,China)
关键词:
加速康复外科; 结直肠癌; 糖尿病; 炎症反应; 营养状况
Keywords:
Accelerated rehabilitation surgery; Colorectal cancer; Diabetes; Inflammatory response; Nutritional status
分类号:
R587.1；R735.3
DOI:
10.3969/j.issn.1006-1959.2019.07.021
文献标志码:
A
摘要:
目的 通过观察ERAS对合并有糖尿病的结直肠癌患者术后炎症反应与营养代谢的影响，明确ERAS对糖尿病人群的安全性与有效性。方法 本研究为随机对照研究，选取2017年1月1日~2018年5月31日入住青岛大学附属医院胃肠外科的80例患者，随机分为对照组和试验组，每组40例。术前均严格控制血糖稳定后行结直肠癌根治术。试验组应用ERAS理念指导患者围手术期处理，对照组进行常规处理，观察两组患者术后基本恢复情况（排气时间、住院时间、住院费用、并发症、胰岛素抵抗），同时比较两组患者炎症反应指标肿瘤坏死因子α（TNF-α）、白介素6（IL-6）、C反应蛋白（CRP）与营养代谢指标白蛋白（ALB）、前白蛋白（PA）、总蛋白（TP）。结果 本研究有75例患者最终完成试验（试验组38例，对照组37例），试验组术后排气时间为（52.84±9.79）h，短于较对照组的（66.14±15.50）h，试验组出院时间为（6.08±1.40）d，短于对照组的（7.83±1.48）d，差异均有统计学意义（P＜0.05）；两组患者术后并发症无明显差异（P＞0.05），试验组术后炎症反应较对照组轻，营养状况较对照组恢复更快，差异有统计学意义（P＜0.05）。两组患者术前胰岛素抵抗无明显差异，术后第1、3天试验组较对照组明显偏低，差异均具有统计学意义（P＜0.05），术后第7天比较差异无统计学意义（P＞0.05）。结论 ERAS可加快胃肠道功能的恢复，缩短住院日，降低住院费用，同时能够减轻患者术后炎症反应，改善患者术后营养状况，加速患者康复。对于合并有糖尿病的结直肠癌病人安全、有效，证明ERAS同样适用于合并有糖尿病的结直肠癌人群。
Abstract:
Objective By observing the effect of ERAS on postoperative inflammatory response and nutrient metabolism in patients with colorectal cancer with diabetes, the safety and efficacy of ERAS in diabetic patients were clarified. Methods This study was a randomized controlled trial of 80 patients admitted to the Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University from January 1, 2017 to May 31, 2018. They were randomly divided into the control group and the experimental group, with 40 cases in each group. Colorectal cancer radical surgery was performed after strict control of blood glucose stability before surgery. The experimental group used the ERAS concept to guide the perioperative management of the patients, and the control group performed routine treatment to observe the basic recovery after operation (exhaust time, hospitalization time, hospitalization expenses, complications, insulin resistance), and compare the two groups of patients. Inflammatory response indicators tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP) and nutritional metabolic indicators albumin (ALB), prealbumin (PA), total protein (TP). Results In this study, 75 patients completed the trial (38 in the experimental group and 37 in the control group). The postoperative exhaust time was (52.84±9.79) h, which was shorter than that of the control group (66.14±15.50) h. The discharge time of the group was (6.08±1.40)d, which was shorter than that of the control group (7.83±1.48)d,the difference was statistically significant (P<0.05). There was no significant difference in postoperative complications between the two groups (P>0.05). The inflammatory response of the experimental group was lighter than that of the control group, and the nutritional status recovered faster than the control group,the difference was statistically significant (P<0.05). There was no significant difference in preoperative insulin resistance between the two groups. On the 1st and 3rd day after operation, the experimental group was significantly lower than the control group,the difference was statistically significant (P<0.05). There was no significant difference on the 7th day after operation(P>0.05). Conclusion ERAS can accelerate the recovery of gastrointestinal function, shorten the hospitalization day, reduce the hospitalization cost, and at the same time reduce the postoperative inflammatory response, improve the postoperative nutritional status of patients, and accelerate the recovery of patients. For patients with colorectal cancer with diabetes, it is safe and effective, and it is proved that ERAS is also suitable for colorectal cancer patients with diabetes.

参考文献/References:


[1]Crosbie AB,Roche LM,Johnson LM,et al.Trends in colorectal cancer incidence among younger adults-Disparities by age,sex,race,ethnicity,and subsite[J].Cancer medicine,2018,7(8):4077-4086.
[2]陈万青,孙可欣,郑荣寿,等.2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2018,27(1):1-14.
[3]赵佳,韩雪,谢梦,等.2型糖尿病并发恶性肿瘤患者的流行病学分析[J].中国慢性病预防与控制, 2018,26(7):514-516.
[4]杨菊红,张立弋,石珍珍,等.合并2型糖尿病的结直肠癌患者的肿瘤组织病理及基因突变特征分析[J].中华内分泌代谢杂志,2018,34(8):655-659.
[5]Wilmore DW,Kehlet H.Management of patients in fast track surgery[J].BMJ,2001,322(7284):473-476.
[6]王东升,仲蓓,孔营,等.结直肠癌患者应用加速康复外科的对照研究[J].中华普通外科杂志,2010,25(7):595-596.
[7]江志伟,黎介寿.加速康复外科的现状与展望[J].中华外科杂志,2016,54(1):6-8.
[8]石学银,邹最.加速康复外科的麻醉管理[J].中华消化外科杂志,2015,14(1):38-42.
[9]中国加速康复外科专家组.中国加速康复外科围手术期管理专家共识(2016)[J].中华外科杂志,2016,54(6):413-418.
[10]Ota H,Ikenaga M,Hasegawa J,et al.Safety and efficacy of an "enhanced recovery after surgery" protocol for patients undergoing colon cancer surgery:a multi-institutional controlled study[J].Surgery today,2017,47(6):668-675.
[11]孔营,周岩冰,王东升,等.加速康复外科对胃癌手术病例体液免疫和临床指标的影响[J].肠外与肠内营养,2009,16(4):205-208.
[12]黎介寿,江志伟.加速康复外科的临床意义不仅仅是缩短住院日[J].中华消化外科杂志,2015,14(1):22-24.
[13]Floh AA,Manlhiot C,Redington AN,et al.Insulin resistance and inflammation are a cause of hyperglycemia after pediatric cardiopulmonary bypass surgery[J].The Journal of thoracic and cardiovascular surgery,2015,150(3):498-504,e491.
[14]Baban B,Thorell A,Nygren J,et al.Determination of insulin resistance in surgery: the choice of method is crucial. Clinical nutrition (Edinburgh, Scotland)[J].2015,34(1):123-128.
[15]Ljungqvist O,Jonathan E.Rhoads lecture 2011:Insulin resistance and enhanced recovery after surgery[J].JPEN J Parenter Enteral Nutr,2012,36(4):389-398.
[16]Johnson AM,Olefsky JM.The origins and drivers of insulin resistance[J].Cell,2013,152(4):673-684.
[17]Watt DG,McSorley ST,Horgan PG,et al.Enhanced Recovery After Surgery:Which Components, If Any,Impact on The Systemic Inflammatory Response Following Colorectal Surgery?:A Systematic Review[J].Medicine,2015,94(36):e1286.
[18]郑朝旭,卢召.加速康复外科在结直肠癌中的应用[J].中华结直肠疾病电子杂志,2018,7(5):402-406.
[19]Vignali A,Elmore U,Cossu A,et al.Enhanced recovery after surgery (ERAS) pathway vs traditional care in laparoscopic rectal resection:a single-center experience[J].Techniques in coloproctology,2016,20(8):559-566.
[20]黎介寿.营养支持治疗与加速康复外科[J].肠外与肠内营养,2015,22(2):65-67.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
　ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Journal of Medical Information,2018,31(07):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]陈学敏,彭 琼.中性粒细胞与淋巴细胞比值联合癌胚抗原对结直肠癌早期诊断的研究[J].医学信息,2019,32(02):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
　CHEN Xue-min,PENG Qiong.Early Diagnosis of Colorectal Cancer by Neutrophil-lymphocyte Ratio Combined with Carcinoembryonic Antigen[J].Journal of Medical Information,2019,32(07):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
[3]李在明,魏正强.外泌体在结直肠癌中的研究进展[J].医学信息,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
　LI Zai-ming,WEI Zheng-qiang.Research Progress of Exosomes in Colorectal Cancer[J].Journal of Medical Information,2019,32(07):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
[4]郭军辉,赵 英,聂志强,等.同伴教育联合加速康复外科在TKA患者日常生活能力改善中的应用[J].医学信息,2019,32(04):66.[doi:10.3969/j.issn.1006-1959.2019.04.023]
　GUO Jun-hui,ZHAO Ying,NIE Zhi-qiang,et al.Application of Peer Education Combined with Accelerated Rehabilitation Surgery in Improving Daily Living Ability of Patients with TKA[J].Journal of Medical Information,2019,32(07):66.[doi:10.3969/j.issn.1006-1959.2019.04.023]
[5]周玲玲,鞠乐乐,颜 玉.结直肠癌患者手术前后血清IGF-1水平变化及临床价值分析[J].医学信息,2019,32(04):121.[doi:10.3969/j.issn.1006-1959.2019.04.039]
　ZHOU Ling-ling,JU Le-le,YAN Yu.Analysis of Changes and Clinical Value of Serum IGF-1 Levels in Patients with Colorectal Cancer before and after Operation[J].Journal of Medical Information,2019,32(07):121.[doi:10.3969/j.issn.1006-1959.2019.04.039]
[6]杜文康,林丽佳,成黎明,等.ERAS策略在儿童传统腹股沟疝修补术中的临床应用[J].医学信息,2019,32(05):61.[doi:10.3969/j.issn.1006-1959.2019.05.019]
　DU Wen-kang,LIN Li-jia,CHENG Li-ming,et al.Clinical Application of ERAS Strategy in Children with Traditional Inguinal Hernia Repair[J].Journal of Medical Information,2019,32(07):61.[doi:10.3969/j.issn.1006-1959.2019.05.019]
[7]陈小玉,白 鍊,贺春香.结直肠癌根治手术患者营养状况调查[J].医学信息,2019,32(05):83.[doi:10.3969/j.issn.1006-1959.2019.05.025]
　CHEN Xiao-yu,BAI Lian,HE Chun-xiang.Investigation on Nutritional Status of Patients Undergoing Radical Surgery for Colorectal Cancer[J].Journal of Medical Information,2019,32(07):83.[doi:10.3969/j.issn.1006-1959.2019.05.025]
[8]王逸飞,王 志,左宏波,等.伊利替康联合替吉奥在晚期结直肠癌治疗的临床研究[J].医学信息,2019,32(07):158.[doi:10.3969/j.issn.1006-1959.2019.07.049]
　WANG Yi-fei,WANG Zhi,ZUO Hong-bo,et al.Clinical Study of Irinotecan Combined with Tegafur,Gimeracil and Oteracil Porassium Capsulesin the Treatment of Advanced Colorectal Cancer[J].Journal of Medical Information,2019,32(07):158.[doi:10.3969/j.issn.1006-1959.2019.07.049]
[9]谢 勇,涂经楷,肖明盛,等.腹腔镜与传统开腹结直肠癌根治术手术效果对比[J].医学信息,2019,32(11):98.[doi:10.3969/j.issn.1006-1959.2019.11.026]
　XIE Yong,TU Jing-kai,XIAO Ming-sheng,et al.Comparative of Laparoscopic and Traditional Open Radical Rectal Cancer Radical Operation[J].Journal of Medical Information,2019,32(07):98.[doi:10.3969/j.issn.1006-1959.2019.11.026]
[10]符青云,欧阳小明,郅 程,等.结直肠癌组织EGFR、BRAF及NRAS基因突变检测及临床意义分析[J].医学信息,2022,35(13):83.[doi:10.3969/j.issn.1006-1959.2022.13.018]
　FU Qing-yun,OUYANG Xiao-ming,ZHI Cheng,et al.Detection and Clinical Significance of EGFR, BRAF and NRAS Gene Mutations in Colorectal Cancer[J].Journal of Medical Information,2022,35(07):83.[doi:10.3969/j.issn.1006-1959.2022.13.018]

更新日期/Last Update: 2019-04-01